Personal neoantigen cancer vaccines: a road not fully paved
EF Fritsch, UE Burkhardt, N Hacohen, CJ Wu - Cancer immunology research, 2020 - AACR
Personal neoantigen–based cancer vaccines are designed to target antigens arising from
tumor-specific mutations within individual cancers and present a tremendous opportunity to …
tumor-specific mutations within individual cancers and present a tremendous opportunity to …
Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved
EF Fritsch, UE Burkhardt… - Cancer immunology …, 2020 - pubmed.ncbi.nlm.nih.gov
Personal neoantigen-based cancer vaccines are designed to target antigens arising from
tumor-specific mutations within individual cancers and present a tremendous opportunity to …
tumor-specific mutations within individual cancers and present a tremendous opportunity to …
[HTML][HTML] Personal neoantigen cancer vaccines: a road not fully paved
EF Fritsch, UE Burkhardt, N Hacohen… - Cancer immunology …, 2020 - ncbi.nlm.nih.gov
Personal neoantigen-based cancer vaccines are designed to target antigens arising from
tumor-specific mutations within individual cancers and present a tremendous opportunity to …
tumor-specific mutations within individual cancers and present a tremendous opportunity to …
Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved.
EF Fritsch, UE Burkhardt, N Hacohen… - Cancer Immunology …, 2020 - europepmc.org
Personal neoantigen-based cancer vaccines are designed to target antigens arising from
tumor-specific mutations within individual cancers and present a tremendous opportunity to …
tumor-specific mutations within individual cancers and present a tremendous opportunity to …